Pharmacists in Inglewood, California


60 Pharmacists found in Inglewood
male pharmacist

Phi T Nguyen


Pharmacist
417 N Oak St, Inglewood, CA 90302
310-671-2600    

male pharmacist

Dr. Pisiwat Kongsomboonvech, PHARMD.


Pharmacist
3471 W Century Blvd, Inglewood, CA 90303
310-677-5937    

female pharmacist

Rachel Cho


Pharmacist
230 N La Brea Ave, Inglewood, CA 90301
310-671-2471     310-671-2873



female pharmacist

Ronnette Morales


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3120 W Imperial Hwy, Inglewood, CA 90303
310-676-1183    

male pharmacist

Sahba Behjati, PHARMD


Pharmacist - Pharmacotherapy
721 S Glasgow Ave, Ste C, Inglewood, CA 90301
866-665-1121    

female pharmacist

Dr. Sheryl Lynn Chow, PHARMD


Pharmacist - Pharmacotherapy
555 E Hardy St, Dept Of Pharmacy (rm 2087, 4th Floor Office), Inglewood, CA 90301
310-680-8730    

female pharmacist

Toyann Grant


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
110 N La Brea Ave, Inglewood, CA 90301
310-419-3307    

female pharmacist

Valerie Stephanie Ramos, PHARMD


Pharmacist
3471 W Century Blvd, Inglewood, CA 90303
310-677-5937    

female pharmacist

Miss Vanessa Chong, PHARM.D


Pharmacist
555 E Hardy St, Inglewood, CA 90301
310-419-8688    

male pharmacist

Vincent I Payne


Pharmacist
500 E Manchester Blvd, Inglewood, CA 90301
310-677-0501     310-677-0053

male pharmacist

William Liang


Pharmacist
222 N Market St, Inglewood, CA 90301
310-677-2171    

female pharmacist

Yasaman Javadzadeh


Pharmacist
4345 W Century Blvd # A, Inglewood, CA 90304
310-672-6078    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.